HOUSE 280117th CongressReferred to the Subcommittee on Health.

Expressing the sense of the House of Representatives that decades of policies rooted in socialism have stifled United States domestic pharmaceutical drug manufacturing and left the United States exposed to the hostile actions and unfair trade practices of the People's Republic of China.

Last Action: 3/29/2021

Actions

2021-02-02Referred to the Subcommittee on Health.
2021-01-12Referred to the House Committee on Energy and Commerce.
2021-01-12Introduced in House
2021-01-12Introduced in House

CRS Summary

As of 2021-01-12 (00)

PDMPs Help Patients Act of 2021

This bill directs the Department of Health and Human Services (HHS) to establish a grant program to test the feasibility of integrating substance use disorder and behavioral health treatment locator tools into prescription drug monitoring programs. HHS may award grants to up to five states.

Cosponsors (5)

Lisa Blunt Rochester (D-DE)
Gus Bilirakis (R-FL)
Alexander Mooney (R-WV)
Jefferson Van Drew (R-NJ)
David Trone (D-MD)

Subjects

Congressional oversight
Drug, alcohol, tobacco use
Health care coverage and access
Health information and medical records
Mental health
Prescription drugs
State and local government operations

Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.